Kyto Technology & Life Science, Inc. (KBPH) financial statements (2022 and earlier)

Company profile

Business Address 13050 PALOMA ROAD
LOS ALTOS HILLS, CA 94022
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6081,4383494
Cash and cash equivalents6081,4383494
Receivables  11
Deferred costs294   
Total current assets:9021,4383495
Noncurrent Assets
Long-term investments and receivables  2,6651,498
Long-term investments  2,6651,498
Deferred costs 170  
Total noncurrent assets: 1702,6651,498
Other undisclosed assets12,1576,821  
TOTAL ASSETS:13,0588,4292,7001,593
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1932622
Other undisclosed accounts payable and accrued liabilities 1932622
Due to related parties 5167
Other undisclosed current liabilities 1,191  
Total current liabilities: 1,4363229
Noncurrent Liabilities
Other undisclosed liabilities147   
Total liabilities:1471,4363229
Stockholders' equity
Stockholders' equity attributable to parent, including:12,9126,9932,6681,564
Common stock133100581
Additional paid in capital44,63139,77235,94331,562
Accumulated other comprehensive loss (32,957)(33,384)(32,611)
Accumulated deficit(31,975)   
Other undisclosed stockholders' equity attributable to parent12378502,613
Total stockholders' equity:12,9126,9932,6681,564
TOTAL LIABILITIES AND EQUITY:13,0588,4292,7001,593

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
Revenues  149
Other undisclosed gross profit(1,113)(769)  
Gross profit:(1,113)(769)149
Operating expenses(237)(769)(788)(239)
Other undisclosed operating loss(769)   
Operating loss:(2,118)(1,538)(773)(230)
Nonoperating income
(Investment Income, Nonoperating)
2,0951,196  
Interest and debt expense   (0)
Other undisclosed income from continuing operations before equity method investments, income taxes1,195   
Income (loss) before gain (loss) on sale of properties:1,172(342)(773)(230)
Other undisclosed net income (loss)(38)769  
Net income (loss) attributable to parent:1,134427(773)(230)
Preferred stock dividends and other adjustments(132)   
Net income (loss) available to common stockholders, diluted:1,002427(773)(230)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
Net income (loss):1,134427(773)(230)
Comprehensive income (loss), net of tax, attributable to parent:1,134427(773)(230)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: